US Patent No: 8,226,944
Number of patents in Portfolio can not be more than 2000
Composition for treating virus infection disease comprising Jab1
Stats
-
Jul 24, 2012
Issued date -
Oct 21, 2010
filing date -
12/909,443
serial no -
In Force
status
Importance
Loading Importance Indicators...
Abstract
Disclosed is a composition for treating or preventing a viral infection or associated disease comprising a Jab1 protein, a nucleic acid having a nucleotide sequence coding for a Jab1 protein or a recombinant virus expressing a Jab1 protein.
Loading the Abstract Image...
First Claim
Related Publications
Loading Related Publications...
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art
| Patent Info | (Count) | # Cites | Year |
|---|---|---|---|
|
|
|||
| 5,948,883 Human CRM1 Protein | 1 | 1997 | |
Patent Citation Ranking
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 3.5 Year Payment | $1600.00 | $800.00 | $400.00 | Jan 24, 2016 |
| 7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | Jan 24, 2020 |
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Jan 24, 2024 |
| Fee | Large entity fee | small entity fee | micro entity fee |
|---|---|---|---|
| Surcharge - 3.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
| Surcharge - 7.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
| Surcharge - 11.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
| Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
| Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |